Ildong to release novel weight loss pill in 2014

Published: 2012-12-13 06:58:00

Updated: 2012-12-13 06:58:00

Ildong Pharm said Monday that it has entered into a marketing and supply agreement with the U.S. based Arena Pharmaceuticals for Belviq (lorcaserin HCl), the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.

Under the agreement, Arena will grant I...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK